Organon & Co (NYSE:OGN)
$ 15.06 0.11 (0.74%) Market Cap: 3.85 Bil Enterprise Value: 11.78 Bil PE Ratio: 2.97 PB Ratio: 7.81 GF Score: 71/100

Q2 2024 Organon & Co Earnings Call Transcript

Aug 06, 2024 / 12:30PM GMT
Release Date Price: $18.65 (-7.63%)
Operator

Thank you for standing by. My name is Mandeep, and I'll be your operator today. At this time, I'd like to welcome everyone to the Organon Q2 2024 earnings call webcast. (Operator Instructions)

I would now like to turn the call over to Jennifer Halchak, Head of Investor Relations. You may begin.

Jennifer Halchak
Organon & Co - Head, Investor Relations

Thank you, operator. Good morning, everyone. Thank you for joining Organon's second-quarter 2024 earnings call. With me today are Kevin Ali, Organon's Chief Executive Officer; and Matt Walsh, our Chief Financial Officer. Also joining us for the Q&A portion of this call is Organon's Head of R&D, Juan Camilo Ariona Ferreira.

Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast. This presentation will also be available following this call on the Events & Presentations section of our Organon Investor Relations website at www.organon.com.

Before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot